Using new QIAseq DNA Targeted Panels with Biomedical Genomics Workbench increases the accuracy of detecting low frequency variants.

We are excited to launch the QIAseq DNA V3 Panel Analysis plug-in for Biomedical Genomics Workbench and Biomedical Genomics Server Solution. The plug-in analyzes and visualizes data from the new QIAseq Targeted DNA Panels — as well as custom DNA panels designed via the Custom Panel Design Service. When combined with Biomedical Genomics Workbench, the QIAseq Targeted DNA Panels enable ‘Digital NGS’ with high accuracy for detecting low frequency variants.

‘Digital NGS’ offers a unique approach, which incorporates unique molecular indices (UMIs) into the starting DNA material before any amplification takes place. This process eliminates errors due to PCR duplicates, which can lead to false positives, false negatives, and an altered allelic fraction/allele frequency of detected variants. By labeling each biomolecule with a UMI, the software is able to filter out PCR artifacts, which increases overall sensitivity and specificity in detecting low frequency variants. In addition, ligation artifacts are automatically removed.

The new QIAseq DNA V3 Panel Analysis plug-in provides a complete, ready-to-use workflow with all necessary analysis tools and many optimized, locked down parameter settings for analyzing Illumina data — making it simple to analyze your UMI-based panel data with Biomedical Genomics Workbench, with no expert bioinformatics expertise needed.

Advances in Genome Biology and Technology

The AGBT Precision Health meeting will take place in Scottsdale, Arizona on September 22-24, 2016. We will be there and we hope you'll come visit us at booth #13.

NGS solutions to empower precision medicine

We offer the most comprehensive sample to insight NGS workflow and we're looking forward to tell you much more about it at the AGBT Precision Health meeting. Stop by our booth #13 to learn more about:

  • QIAseq targeted DNA panels and the ability to determine the sensitivity of a panel at a base level
  • QIAseq targeted RNAscan panels to detect known and novel gene fusions using NGS
  • QIAGEN Bioinformatics and its easy-to-use solutions for hereditary diseases and cancer for any lab
  • World class PCR assays for solid tumor and blood cancer biomarker research

Poster presentation

Leveraging biological pathways and network analytics to identify disease-causing mutations from clinical genome and exome sequence (CGES) data
Poster #510
Presenter: Sohela Shah, PhD, Genome Scientist, QIAGEN Bioinformatics
Date and time: September 23, 1:30 p.m. - 3:00 p.m.

Learn more about our hereditary disease solution
Get more details about AGBT Precision Health

Sample to Insight
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.